Skip to main content
Top
Published in: European Journal of Medical Research 1/2019

Open Access 01-12-2019 | Care | Research

Orthogeriatric treatment reduces potential inappropriate medication in older trauma patients: a retrospective, dual-center study comparing conventional trauma care and co-managed treatment

Authors: Johannes Gleich, Daniel Pfeufer, Christian Zeckey, Wolfgang Böcker, Markus Gosch, Christian Kammerlander, Carl Neuerburg

Published in: European Journal of Medical Research | Issue 1/2019

Login to get access

Abstract

Background

Multimorbidity and polypharmacy are common challenges in the treatment of older trauma patients. Therefore, various integrated care models were developed over the last few years, merging the expertise of geriatricians and trauma surgeons. The aim of this study was to evaluate, if the number of prescriptions of potentially inappropriate medication (PIM) could be reduced in these patients by an interdisciplinary co-managed concept compared to conventional trauma care.

Methods

We conducted a retrospective, dual-center cohort study, including all patients aged 70 years and older admitted with a fracture of the hip or the proximal humerus within the study period. Patients were treated in the universities department of trauma surgery with two different hospital sites, one with conventional trauma care (CTC) and the other one with a certified orthogeriatric trauma unit (OGC). Based on the STOPP/START criteria by O´Mahony et al., PIMs were defined, which should be avoided in (ortho)geriatric patients. Medical records of each patient were analyzed at discharge. Besides patients basic information, all prescribed drugs, changes in the medication plan and who carried out these changes were collected. For statistical analysis based on the data quality and distribution, the t test, Mann–Whitney U test and the Chi-square test were used.

Results

A total of 95 patients were included, 73 of them females, with an average age of 82.59 years (SD ± 6.96). Mean length of hospital stay was 12.98 at CTC and 13.36 days at OGC (p = 0.536). Among conventional care (41 patients), prescription of one or more PIMs was found in 85.4% of the patients, whereas at the orthogeriatric ward (54 patients) only in 22.2% (p < 0.001). Besides that, changes in medication were made for 48.1% of the patients during their stay on the orthogeriatric ward.

Conclusions

Our findings show that an integrated care concept can reduce the number of prescriptions of PIMs significantly and potentially avoids adverse drug reactions and additional burdens in older trauma patients.
Literature
1.
go back to reference Tsuda T. Epidemiology of fragility fractures and fall prevention in the elderly: a systematic review of the literature. Curr Orthop Pract. 2017;28(6):580–5.CrossRef Tsuda T. Epidemiology of fragility fractures and fall prevention in the elderly: a systematic review of the literature. Curr Orthop Pract. 2017;28(6):580–5.CrossRef
2.
go back to reference Friedman SM, Mendelson DA. Epidemiology of fragility fractures. Clin Geriatr Med. 2014;30(2):175–81.CrossRef Friedman SM, Mendelson DA. Epidemiology of fragility fractures. Clin Geriatr Med. 2014;30(2):175–81.CrossRef
3.
go back to reference Sjoberg C, Bladh L, Klintberg L, Mellstrom D, Ohlsson C, Wallerstedt SM. Treatment with fall-risk-increasing and fracture-preventing drugs before and after a hip fracture: an observational study. Drugs Aging. 2010;27(8):653–61.CrossRef Sjoberg C, Bladh L, Klintberg L, Mellstrom D, Ohlsson C, Wallerstedt SM. Treatment with fall-risk-increasing and fracture-preventing drugs before and after a hip fracture: an observational study. Drugs Aging. 2010;27(8):653–61.CrossRef
4.
go back to reference Morin L, Johnell K, Laroche ML, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289–98.CrossRef Morin L, Johnell K, Laroche ML, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289–98.CrossRef
5.
go back to reference Hu F, Jiang C, Shen J, Tang P, Wang Y. Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis. Injury. 2012;43(6):676–85.CrossRef Hu F, Jiang C, Shen J, Tang P, Wang Y. Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis. Injury. 2012;43(6):676–85.CrossRef
6.
go back to reference Muller-Mai CM, Schulze Raestrup US, Kostuj T, Dahlhoff G, Gunster C, Smektala R. One-year outcomes for proximal femoral fractures: posthospital analysis of mortality and care levels based on health insurance data. Unfallchirurg. 2015;118(9):780–94.CrossRef Muller-Mai CM, Schulze Raestrup US, Kostuj T, Dahlhoff G, Gunster C, Smektala R. One-year outcomes for proximal femoral fractures: posthospital analysis of mortality and care levels based on health insurance data. Unfallchirurg. 2015;118(9):780–94.CrossRef
7.
go back to reference Wilson LA, Gooding BW, Manning PA, Wallace WA, Geoghegan JM. Risk factors and predictors of mortality for proximal humeral fractures. Shoulder Elbow. 2014;6(2):95–9.CrossRef Wilson LA, Gooding BW, Manning PA, Wallace WA, Geoghegan JM. Risk factors and predictors of mortality for proximal humeral fractures. Shoulder Elbow. 2014;6(2):95–9.CrossRef
8.
go back to reference Gosch M, Wortz M, Nicholas JA, Doshi HK, Kammerlander C, Lechleitner M. Inappropriate prescribing as a predictor for long-term mortality after hip fracture. Gerontology. 2014;60(2):114–22.CrossRef Gosch M, Wortz M, Nicholas JA, Doshi HK, Kammerlander C, Lechleitner M. Inappropriate prescribing as a predictor for long-term mortality after hip fracture. Gerontology. 2014;60(2):114–22.CrossRef
9.
go back to reference Iaboni A, Rawson K, Burkett C, Lenze EJ, Flint AJ. Potentially inappropriate medications and the time to full functional recovery after hip fracture. Drugs Aging. 2017;34(9):723–8.CrossRef Iaboni A, Rawson K, Burkett C, Lenze EJ, Flint AJ. Potentially inappropriate medications and the time to full functional recovery after hip fracture. Drugs Aging. 2017;34(9):723–8.CrossRef
10.
go back to reference Finlayson E, Maselli J, Steinman MA, Rothberg MB, Lindenauer PK, Auerbach AD. Inappropriate medication use in older adults undergoing surgery: a national study. J Am Geriatr Soc. 2011;59(11):2139–44.CrossRef Finlayson E, Maselli J, Steinman MA, Rothberg MB, Lindenauer PK, Auerbach AD. Inappropriate medication use in older adults undergoing surgery: a national study. J Am Geriatr Soc. 2011;59(11):2139–44.CrossRef
11.
go back to reference Pioli G, Giusti A, Barone A. Orthogeriatric care for the elderly with hip fractures: where are we? Aging Clin Exp Res. 2008;20(2):113–22.CrossRef Pioli G, Giusti A, Barone A. Orthogeriatric care for the elderly with hip fractures: where are we? Aging Clin Exp Res. 2008;20(2):113–22.CrossRef
12.
go back to reference Kammerlander C, Roth T, Friedman SM, Suhm N, Luger TJ, Kammerlander-Knauer U. Ortho-geriatric service—a literature review comparing different models. Osteoporos Int. 2010;21:637–46.CrossRef Kammerlander C, Roth T, Friedman SM, Suhm N, Luger TJ, Kammerlander-Knauer U. Ortho-geriatric service—a literature review comparing different models. Osteoporos Int. 2010;21:637–46.CrossRef
13.
go back to reference Folbert EC, Hegeman JH, Vermeer M, Regtuijt EM, van der Velde D, ten Duis HJ, et al. Improved 1-year mortality in elderly patients with a hip fracture following integrated orthogeriatric treatment. Osteoporos Int. 2017;28(1):269–77.CrossRef Folbert EC, Hegeman JH, Vermeer M, Regtuijt EM, van der Velde D, ten Duis HJ, et al. Improved 1-year mortality in elderly patients with a hip fracture following integrated orthogeriatric treatment. Osteoporos Int. 2017;28(1):269–77.CrossRef
14.
go back to reference Henderson CY, Shanahan E, Butler A, Lenehan B, O’Connor M, Lyons D, et al. Dedicated orthogeriatric service reduces hip fracture mortality. Ir J Med Sci. 2017;186(1):179–84.CrossRef Henderson CY, Shanahan E, Butler A, Lenehan B, O’Connor M, Lyons D, et al. Dedicated orthogeriatric service reduces hip fracture mortality. Ir J Med Sci. 2017;186(1):179–84.CrossRef
15.
go back to reference Foerch S, Kretschmer R, Haufe T, Plath J, Mayr E. Orthogeriatric combined management of elderly patients with proximal femoral fracture: results of a 1-year follow-up. Geriatr Orthop Surg Rehabil. 2017;8(2):109–14.CrossRef Foerch S, Kretschmer R, Haufe T, Plath J, Mayr E. Orthogeriatric combined management of elderly patients with proximal femoral fracture: results of a 1-year follow-up. Geriatr Orthop Surg Rehabil. 2017;8(2):109–14.CrossRef
16.
go back to reference Lisk R, Yeong K. Reducing mortality from hip fractures: a systematic quality improvement programme. BMJ Qual Improv Rep. 2014;3(1):u205006-w2103.CrossRef Lisk R, Yeong K. Reducing mortality from hip fractures: a systematic quality improvement programme. BMJ Qual Improv Rep. 2014;3(1):u205006-w2103.CrossRef
17.
go back to reference O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRef O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRef
18.
go back to reference Mahony DO, Sullivan DO, Byrne S, Connor MNO, Ryan C, Gallagher P. Corrigendum: STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2018;47(3):489.CrossRef Mahony DO, Sullivan DO, Byrne S, Connor MNO, Ryan C, Gallagher P. Corrigendum: STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2018;47(3):489.CrossRef
19.
go back to reference Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Deutsches Arzteblatt Int. 2010;107(31–32):543–51. Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Deutsches Arzteblatt Int. 2010;107(31–32):543–51.
20.
go back to reference Collinge CA, McWilliam-Ross K, Beltran MJ, Weaver T. Measures of clinical outcome before, during, and after implementation of a comprehensive geriatric hip fracture program: is there a learning curve? J Orthop Trauma. 2013;27(12):672–6.CrossRef Collinge CA, McWilliam-Ross K, Beltran MJ, Weaver T. Measures of clinical outcome before, during, and after implementation of a comprehensive geriatric hip fracture program: is there a learning curve? J Orthop Trauma. 2013;27(12):672–6.CrossRef
21.
go back to reference Schray D, Neuerburg C, Stein J, Gosch M, Schieker M, Bocker W, et al. Value of a coordinated management of osteoporosis via Fracture Liaison Service for the treatment of orthogeriatric patients. Eur J Trauma Emerg Surg. 2016;42(5):559–64.CrossRef Schray D, Neuerburg C, Stein J, Gosch M, Schieker M, Bocker W, et al. Value of a coordinated management of osteoporosis via Fracture Liaison Service for the treatment of orthogeriatric patients. Eur J Trauma Emerg Surg. 2016;42(5):559–64.CrossRef
22.
go back to reference Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P. Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977–2001. J Bone Miner Res. 2009;24(7):1299–307.CrossRef Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P. Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977–2001. J Bone Miner Res. 2009;24(7):1299–307.CrossRef
23.
go back to reference Chimirri S, Aiello R, Mazzitello C, Mumoli L, Palleria C, Altomonte M, et al. Vertigo/dizziness as a Drugs’ adverse reaction. J Pharmacol Pharmacother. 2013;4(Suppl 1):S104–9.PubMedPubMedCentral Chimirri S, Aiello R, Mazzitello C, Mumoli L, Palleria C, Altomonte M, et al. Vertigo/dizziness as a Drugs’ adverse reaction. J Pharmacol Pharmacother. 2013;4(Suppl 1):S104–9.PubMedPubMedCentral
24.
go back to reference Sousa J, Alves G, Fortuna A, Falcao A. Third and fourth generation fluoroquinolone antibacterials: a systematic review of safety and toxicity profiles. Curr Drug Saf. 2014;9(2):89–105.CrossRef Sousa J, Alves G, Fortuna A, Falcao A. Third and fourth generation fluoroquinolone antibacterials: a systematic review of safety and toxicity profiles. Curr Drug Saf. 2014;9(2):89–105.CrossRef
25.
go back to reference Ognibene S, Vazzana N, Giumelli C, Savoldi L, Braglia L, Chesi G. Hospitalisation and morbidity due to adverse drug reactions in elderly patients: a single-centre study. Intern Med J. 2018;48(10):1192–7.CrossRef Ognibene S, Vazzana N, Giumelli C, Savoldi L, Braglia L, Chesi G. Hospitalisation and morbidity due to adverse drug reactions in elderly patients: a single-centre study. Intern Med J. 2018;48(10):1192–7.CrossRef
26.
go back to reference Thorell K, Ranstad K, Midlov P, Borgquist L, Halling A. Is use of fall risk-increasing drugs in an elderly population associated with an increased risk of hip fracture, after adjustment for multimorbidity level: a cohort study. BMC Geriatr. 2014;14:131.CrossRef Thorell K, Ranstad K, Midlov P, Borgquist L, Halling A. Is use of fall risk-increasing drugs in an elderly population associated with an increased risk of hip fracture, after adjustment for multimorbidity level: a cohort study. BMC Geriatr. 2014;14:131.CrossRef
27.
go back to reference Milos V, Bondesson A, Magnusson M, Jakobsson U, Westerlund T, Midlov P. Fall risk-increasing drugs and falls: a cross-sectional study among elderly patients in primary care. BMC Geriatr. 2014;14:40.CrossRef Milos V, Bondesson A, Magnusson M, Jakobsson U, Westerlund T, Midlov P. Fall risk-increasing drugs and falls: a cross-sectional study among elderly patients in primary care. BMC Geriatr. 2014;14:40.CrossRef
28.
go back to reference Kragh Ekstam A, Elmstahl S. Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study. Clin Interv Aging. 2016;11:489–96.CrossRef Kragh Ekstam A, Elmstahl S. Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study. Clin Interv Aging. 2016;11:489–96.CrossRef
30.
go back to reference Lanas A, Carrera-Lasfuentes P, Arguedas Y, Garcia S, Bujanda L, Calvet X, et al. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. Clin Gastroenterol Hepatol. 2015;13(5):906-12.e2.CrossRef Lanas A, Carrera-Lasfuentes P, Arguedas Y, Garcia S, Bujanda L, Calvet X, et al. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. Clin Gastroenterol Hepatol. 2015;13(5):906-12.e2.CrossRef
Metadata
Title
Orthogeriatric treatment reduces potential inappropriate medication in older trauma patients: a retrospective, dual-center study comparing conventional trauma care and co-managed treatment
Authors
Johannes Gleich
Daniel Pfeufer
Christian Zeckey
Wolfgang Böcker
Markus Gosch
Christian Kammerlander
Carl Neuerburg
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Care
Published in
European Journal of Medical Research / Issue 1/2019
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-019-0362-0

Other articles of this Issue 1/2019

European Journal of Medical Research 1/2019 Go to the issue